Insmed Inc. | Key People and Executives
William H. Lewis
President, Chief Executive Officer & Director
Donald J. Hayden
Non-Executive Chairman
David Richard Brennan
Independent Director
Myrtle S. Potter
Independent Director
Steinar Johan Engelsen
Independent Director
Melvin Sharoky
Independent Director
David W. J. McGirr
Independent Director
Alfred F. Altomari
Independent Director
William H. Lewis
President, Chief Executive Officer & Director
Paolo Tombesi
Chief Financial Officer
Paul Streck
Chief Medical Officer
Walter R. Perkins
Chief Technology Officer
John D. Soriano
Chief Compliance Officer
Eugene Jeffrey Sullivan
Chief Product Strategy Officer
Roger Adsett
Chief Commercial Officer
John Goll
Vice President & Corporate Controller
Blaine T. Davis
Investor Relations Contact
S. Nicole Schaeffer
Senior VP-Human Resources & Corporate Services
Christine A. Pellizzari
Chief Legal Officer & Secretary
Donald J. Hayden
Non-Executive Chairman
David Richard Brennan
Independent Director
Myrtle S. Potter
Independent Director
Steinar Johan Engelsen
Independent Director
Melvin Sharoky
Independent Director
David W. J. McGirr
Independent Director
Alfred F. Altomari
Independent Director
| Address |
10 Finderne Avenue
Bridgewater New Jersey 08807
United States
|
|
Employees
|
- |
| Website |
http://www.insmed.com |
| Updated |
07/08/2019 |
| Insmed, Inc. operates as a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. It focuses on the development and commercialization of ARIKAYCE or liposomal amikacin for inhalation (LAI), for at least two identified orphan patient populations: patients with nontuberculous mycobacteria lung disease and cystic fibrosis patients with Pseudomonas aeruginosa lung infections. The company was founded on November 29, 1999 and is headquartered in Bridgewater, NJ. |
